Blog · Evidence, in plain language

Exercise in your patient's depression care.

Your patients hear the exercise advice everywhere, and the harder version of the question lands in your room: should I be doing this instead of the rest of my treatment? In January 2026 the Cochrane network updated its review of exercise for depression, and its findings are specific enough to answer with. This post sets out what the reviews found, what they could not establish, and which parts of the question are yours and which are the prescriber's.

By Karel Winner, DNP, PMHNP-BC · Published October 6, 2026

What the reviews found

The Cochrane update covered 73 randomized trials with 4,985 adults with depression. Exercise reduced symptoms by a moderate amount compared with no treatment or a control activity. In 10 trials that compared exercise directly with psychological therapy, symptom reduction was about the same in both groups. In 5 trials comparing exercise with antidepressant medication, the results were also about the same. A 2024 analysis in The BMJ pooled 218 studies with 14,170 people with major depression and ranked walking or jogging, yoga, and strength training highest among the exercise types. A British Journal of Sports Medicine umbrella review combined 97 earlier reviews, 1,039 trials, and 128,119 participants, and found medium-sized improvements in depression, anxiety, and psychological distress.

The limits matter as much as the findings. Cochrane rated the therapy comparison moderate certainty and most other comparisons low certainty, and almost no trials followed patients after the programs ended, so durability is unknown. The BMJ authors found only one study at low risk of bias and rated their confidence low to very low. The umbrella review found most of its source reviews critically low in quality. The reviews also disagree about intensity: the BMJ and umbrella analyses link harder exercise to larger gains, while Cochrane found light to moderate intensity looking better than vigorous. When a patient asks whether exercise works, the supportable answer is that it reduces symptoms moderately on average, that the direct comparisons with therapy and medication are few and small, and that no one can yet name the best type or intensity for a particular person.

What belongs in the therapy room

The planning work is therapy work. Depression attacks the exact capacities a new activity requires, so the useful questions are the behavioral ones you already ask: what is small enough to survive a bad week, what has worked before, what gets in the way, and what the patient will count as having done it. A collapse in activity is also clinical information. A patient who has stopped walking, stopped leaving the house, or stopped a routine that was holding is often reporting worsening depression in behavioral form, and naming that pattern in session gives the patient language for it.

The comparison question deserves a direct answer in the room, because patients ask therapists first. The trials do not support trading therapy for exercise, and a patient who is considering dropping treatment for a workout plan should hear that the head to head evidence is a handful of small trials, not a verdict. Helping the patient bring that plan to the prescriber as a question, with their history attached, is the move that protects the treatment.

What belongs to the prescriber

Medical clearance is not a therapy judgment. A patient with a heart condition, joint disease, a history involving eating or compulsive exercise, or a medicine that affects energy, appetite, or blood pressure needs the activity question settled with the clinician who holds the full medical picture. The same applies to any proposal to change, reduce, or stop a psychiatric medicine because exercise is going well. Those decisions turn on diagnosis, past response, and relapse history, and they belong to the patient and the prescriber. The therapist who routes the question instead of answering it keeps the patient's care in one piece.

Sources

Clegg and colleagues, Cochrane Database of Systematic Reviews (January 2026): an updated review of exercise for depression, 73 randomized trials with 4,985 participants, adding 35 trials to the previous version. Cochrane Library.

Noetel and colleagues, The BMJ (2024): a systematic review and network meta-analysis of exercise for major depression, 218 studies with 14,170 participants. The BMJ.

Singh and colleagues, British Journal of Sports Medicine (2023): an umbrella review of physical activity and symptoms of depression, anxiety, and distress, covering 97 reviews, 1,039 trials, and 128,119 participants. PubMed record.

If a patient is having thoughts of harming themselves, the crisis standard applies: call or text 988, text HOME to 741741 for Crisis Text Line, or see the crisis page.